Prévisions du marché de la bioproduction en Asie-Pacifique jusqu\'en 2030 – Analyse régionale – par produit (produits biologiques et biosimilaires, vaccins, thérapies cellulaires et géniques, thérapies à base d\'acide nucléique et autres), application (polyarthrite rhumatoïde, troubles hématologiques, cancer, diabète, maladies cardiovasculaires et autres) ), l\'équipement (équipement en amont, équipement en aval, bioréacteurs, consommables et accessoires) et l\'utilisateur final (sociétés biopharmaceutiques, organisations de fabrication sous contrat et autres)

BMIRE00030060 | Pages: 117 | Biotechnology | May 2024 | Type: Regional | Status: Published
Le marché de la bioproduction en Asie-Pacifique était évalué à 4 791,34 millions de dollars américains en 2022 et devrait atteindre 14 612,30 millions de dollars américains d’ici 2030 ; on estime qu\'il enregistrera un TCAC de 15,0 % de 2022 à 2030.

L\'expiration des brevets de produits biologiques à succès stimule le marché de la bioproduction en Asie-Pacifique. Les produits biologiques représentent de nouvelles thérapies prometteuses pour des maladies auparavant incurables et deviennent très importants sur le marché pharmaceutique. Les brevets sur les produits biologiques princeps devraient expirer dans les années à venir.

Les dates d\'expiration estimées des brevets et des exclusivités pour les produits biologiques les plus vendus sont indiquées dans le tableau suivant.

Dates d\'expiration des produits biologiques



Produits biologiques

Dates d\'expiration

Avastin

Janvier 2022

Cyramza

Mai 2023

Adcetris

Août 2023

Abthrax < br> Octobre 2024

Gazyva/Gazyvaro

Novembre 2024

Darzalex

Mai 2026

Ocrevus

Avril 2027

Emgality

Septembre 2028

Hemlibra

Février 2028

Llumetri

Mars 2028

Imfinzi

Septembre 2028

Mylotarg

Avril 2028

Imfinzi

Septembre 2028

Mylotarg

Avril 2028

Sylvant

Juillet 2034

L\'expiration des brevets et d\'autres droits de propriété intellectuelle sur les produits biologiques d\'origine créeront le besoin d\'introduire de nouveaux biosimilaires à l\'avenir. En conséquence, la concurrence entre les acteurs du marché va s’intensifier dans le secteur dans les années à venir. Ainsi, l’expiration des brevets des produits biologiques à succès devrait créer des opportunités lucratives pour le marché de la bioproduction au cours de la période de prévision.

Aperçu du marché de la bioproduction en Asie-Pacifique

Le marché de la bioproduction en Asie-Pacifique est segmenté en Chine, au Japon, en Inde, en Corée du Sud, en Australie, en Corée du Sud et dans le reste de l\'Asie-Pacifique. La croissance du marché en Asie-Pacifique devrait croître à un rythme plus rapide en raison de facteurs tels que le besoin croissant de solutions de traitement supérieures, l’accent croissant mis sur les activités de recherche et développement et les scénarios réglementaires favorables. De plus, on estime que l’augmentation des investissements et le développement des infrastructures de soins de santé pour stimuler les activités de recherche stimuleront le marché de la bioproduction en Asie-Pacifique au cours de la période 2022-2030.

En Chine, la demande de soins de santé augmente rapidement. Des facteurs tels que la population gériatrique croissante, l’incidence croissante des maladies chroniques et les initiatives gouvernementales croissantes dans le secteur de la santé stimulent le marché de la thérapie cellulaire en Chine. Les améliorations apportées aux régimes d\'assurance médicale de base et privés ont également accéléré la croissance du secteur médical dans le pays. La hausse des revenus a conduit à une demande de services de santé plus sophistiqués. L’augmentation de la population gériatrique a entraîné une augmentation de la communauté médicale spécialisée dans le pays. En Chine, la prévalence croissante du cancer va probablement accroître l’adoption de la thérapie cellulaire. Selon le Registre central national du cancer de Chine, 4,3 millions de nouveaux cas de cancer ont été enregistrés en Chine.



Revenus et prévisions du marché de la bioproduction en Asie-Pacifique jusqu\'en 2030 (en millions de dollars américains)

Segmentation du marché de la bioproduction en Asie-Pacifique



Le marché de la bioproduction en Asie-Pacifique est classé en produit, application, équipement et utilisateur final. , et le pays.

En fonction du produit, le marché de la bioproduction de l\'Asie-Pacifique est segmenté en produits biologiques et biosimilaires, vaccins, thérapies cellulaires et géniques, thérapies à base d\'acide nucléique et autres. Le segment des produits biologiques et biosimilaires détenait la plus grande part de marché de la bioproduction en Asie-Pacifique en 2022.

En termes d\'application, le marché de la bioproduction en Asie-Pacifique est segmenté en polyarthrite rhumatoïde, troubles hématologiques, cancer, diabète, maladies cardiovasculaires et autres. Le segment du cancer détenait la plus grande part de marché de la bioproduction en Asie-Pacifique en 2022.

Par équipement, le marché de la bioproduction en Asie-Pacifique est divisé en équipements en amont, équipements en aval, bioréacteurs, consommables et accessoires. Le segment des consommables et des accessoires détenait la plus grande part de marché de la bioproduction en Asie-Pacifique en 2022.

En termes d\'utilisateur final, le marché de la bioproduction en Asie-Pacifique est classé en sociétés biopharmaceutiques, organisations de fabrication sous contrat et autres. Le segment des sociétés biopharmaceutiques détenait la plus grande part de marché de la bioproduction en Asie-Pacifique en 2022.

Par pays, le marché de la bioproduction en Asie-Pacifique est segmenté en Australie, Chine, Inde, Japon, Corée du Sud et reste de l\'Asie-Pacifique. La Chine a dominé la part de marché de la bioproduction en Asie-Pacifique en 2022.

Lonza Group AG, bbi-biotech GmbH, Danaher Corp, Sartorius AG, FUJIFILM Irvine Scientific Inc, Thermo Fisher Scientific Inc, Merck KGaA, F. Hoffmann-La Roche Ltd, et Bio-Rad Laboratories Inc. comptent parmi les principales sociétés opérant sur le marché de la bioproduction en Asie-Pacifique.

Table of Content

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Bioproduction Market - Key Industry Dynamics

4.1 Market Drivers

4.1.1 Rising Adoption of Regenerative Medicines

4.1.2 Increasing Prevalence of Chronic Diseases

4.2 Market Restraints

4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing

4.3 Market Opportunities

4.3.1 Patent Expiry of Blockbuster Biologics

4.4 Future Trends

4.4.1 Shift Toward Automated Cell Therapy Manufacturing

4.5 Impact Analysis

5. Bioproduction Market - Asia Pacific Market Analysis

5.1 Asia Pacific Bioproduction Market Revenue (US$ Mn), 2020 - 2030

6. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Product

6.1 Overview

6.2 Asia Pacific Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)

6.3 Biologics and Biosimilars

6.3.1 Overview

6.3.2 Biologics and Biosimilars: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Vaccines

6.4.1 Overview

6.4.2 Vaccines: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

6.5 Cell and Gene Therapies

6.5.1 Overview

6.5.2 Cell and Gene Therapies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

6.6 Nucleic Acid Therapeutics

6.6.1 Overview

6.6.2 Nucleic Acid Therapeutics: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

6.7 Others

6.7.1 Overview

6.7.2 Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Application

7.1 Overview

7.2 Asia Pacific Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)

7.3 Cancer

7.3.1 Overview

7.3.2 Cancer: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Cardiovascular Diseases

7.4.1 Overview

7.4.2 Cardiovascular Diseases: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Rheumatoid Arthritis

7.5.1 Overview

7.5.2 Rheumatoid Arthritis: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

7.6 Hematological Disorders

7.6.1 Overview

7.6.2 Hematological Disorders: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

7.7 Diabetes

7.7.1 Overview

7.7.2 Diabetes: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

7.8 Others

7.8.1 Overview

7.8.2 Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Equipment

8.1 Overview

8.2 Asia Pacific Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)

8.3 Consumables and Accessories

8.3.1 Overview

8.3.2 Consumables and Accessories: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Downstream Equipment

8.4.1 Overview

8.4.2 Downstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Bioreactors

8.5.1 Overview

8.5.2 Bioreactors: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

8.5.2.1 Asia Pacific: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)

8.6 Upstream Equipment

8.6.1 Overview

8.6.2 Upstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by End User

9.1 Overview

9.2 Asia Pacific Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)

9.3 Biopharmaceutical Companies

9.3.1 Overview

9.3.2 Biopharmaceutical Companies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Contract Manufacturing Organizations

9.4.1 Overview

9.4.2 Contract Manufacturing Organizations: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

9.5 Others

9.5.1 Overview

9.5.2 Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis

10.1 Asia Pacific: Bioproduction Market

10.1.1 Asia Pacific: Bioproduction Market, by Country, 2022 & 2030 (%)

10.1.1.1 China: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 China: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.2 China: Bioproduction Market, by Product, 2020-2030 (US$ Million)

10.1.1.1.3 China: Bioproduction Market, by Application, 2020-2030 (US$ Million)

10.1.1.1.4 China: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)

10.1.1.1.4.1 China: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)

10.1.1.1.5 China: Bioproduction Market, by End User, 2020-2030 (US$ Million)

10.1.1.2 India: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 India: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.3 India: Bioproduction Market, by Product, 2020-2030 (US$ Million)

10.1.1.2.4 India: Bioproduction Market, by Application, 2020-2030 (US$ Million)

10.1.1.2.5 India: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)

10.1.1.2.5.1 India: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)

10.1.1.2.6 India: Bioproduction Market, by End User, 2020-2030 (US$ Million)

10.1.1.3 Japan: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 Japan: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.3 Japan: Bioproduction Market, by Product, 2020-2030 (US$ Million)

10.1.1.3.4 Japan: Bioproduction Market, by Application, 2020-2030 (US$ Million)

10.1.1.3.5 Japan: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)

10.1.1.3.5.1 Japan: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)

10.1.1.3.6 Japan: Bioproduction Market, by End User, 2020-2030 (US$ Million)

10.1.1.4 Australia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.1 Overview

10.1.1.4.2 Australia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.3 Australia: Bioproduction Market, by Product, 2020-2030 (US$ Million)

10.1.1.4.4 Australia: Bioproduction Market, by Application, 2020-2030 (US$ Million)

10.1.1.4.5 Australia: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)

10.1.1.4.5.1 Australia: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)

10.1.1.4.6 Australia: Bioproduction Market, by End User, 2020-2030 (US$ Million)

10.1.1.5 South Korea: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.1 Overview

10.1.1.5.2 South Korea: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.3 South Korea: Bioproduction Market, by Product, 2020-2030 (US$ Million)

10.1.1.5.4 South Korea: Bioproduction Market, by Application, 2020-2030 (US$ Million)

10.1.1.5.5 South Korea: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)

10.1.1.5.5.1 South Korea: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)

10.1.1.5.6 South Korea: Bioproduction Market, by End User, 2020-2030 (US$ Million)

10.1.1.6 Rest of Asia Pacific: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.1 Overview

10.1.1.6.2 Rest of Asia Pacific: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.3 Rest of Asia Pacific: Bioproduction Market, by Product, 2020-2030 (US$ Million)

10.1.1.6.4 Rest of Asia Pacific: Bioproduction Market, by Application, 2020-2030 (US$ Million)

10.1.1.6.5 Rest of Asia Pacific: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)

10.1.1.6.5.1 Rest of Asia Pacific: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)

10.1.1.6.6 Rest of Asia Pacific: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)

11. Bioproduction Market-Industry Landscape

11.1 Overview

11.2 Growth Strategies in the Bioproduction Market

11.3 Inorganic Growth Strategies

11.3.1 Overview

11.4 Organic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 . Lonza Group AG

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 bbi-biotech GmbH

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Danaher Corp

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Sartorius AG

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 FUJIFILM Irvine Scientific Inc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Thermo Fisher Scientific Inc

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Merck KGaA

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 F. Hoffmann-La Roche Ltd

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Bio-Rad Laboratories Inc

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

13. Appendix

13.1 About Us

13.2 Glossary of Terms

 

 

?

List of Tables

Table 1. Asia Pacific Bioproduction Market Segmentation

Table 2. Asia Pacific Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)

Table 3. China Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 4. China Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 5. China Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)

Table 6. China Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)

Table 7. China Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 8. India Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 9. India Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 10. India Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)

Table 11. India Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)

Table 12. India Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 13. Japan Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 14. Japan Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 15. Japan Bioproduction Market, by Equipment- Revenue and Forecast to 2030 (US$ Million)

Table 16. Japan Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)

Table 17. Japan Bioproduction Market, by End User- Revenue and Forecast to 2030 (US$ Million)

Table 18. Australia Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 19. Australia Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 20. Australia Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)

Table 21. Australia Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)

Table 22. Australia Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 23. South Korea Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 24. South Korea Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 25. South Korea Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)

Table 26. South Korea Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)

Table 27. South Korea Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 28. Rest of Asia Pacific Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 29. Rest of Asia Pacific Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 30. Rest of Asia Pacific Bioproduction Market, by Equipment- Revenue and Forecast to 2030 (US$ Million)

Table 31. Rest of Asia Pacific Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)

Table 32. Rest of Asia Pacific Bioproduction Market, by Equipment- Revenue and Forecast to 2030 (US$ Million)

Table 33. Recent Inorganic Growth Strategies in the Bioproduction Market

Table 34. Recent Organic Growth Strategies in the Bioproduction Market

Table 35. Glossary of Terms, Bioproduction Market

?

List of Figures

Figure 1. Asia Pacific Bioproduction Market Segmentation, By Country

Figure 2. Asia Pacific Bioproduction Market: Key Industry Dynamics

Figure 3. Asia Pacific Bioproduction Market: Impact Analysis of Drivers and Restraints

Figure 4. Asia Pacific Bioproduction Market Revenue (US$ Mn), 2020 - 2030

Figure 5. Asia Pacific Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)

Figure 6. Biologics and Biosimilars: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Vaccines: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Cell and Gene Therapies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Nucleic Acid Therapeutics: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Asia Pacific Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)

Figure 12. Cancer: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Cardiovascular Diseases: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Rheumatoid Arthritis: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Hematological Disorders: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Diabetes: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Asia Pacific Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)

Figure 19. Consumables and Accessories: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Downstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Bioreactors: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Upstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Asia Pacific Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)

Figure 24. Biopharmaceutical Companies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. Contract Manufacturing Organizations: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 26. Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 27. Asia Pacific: Bioproduction Market, by Key Country - Revenue (2022) (US$ Million)

Figure 28. Asia Pacific: Bioproduction Market, by Country, 2022 & 2030 (%)

Figure 29. China: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 30. India: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 31. Japan: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 32. Australia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 33. South Korea: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 34. Rest of Asia Pacific: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 35. Growth Strategies in the Bioproduction Market

1. Lonza Group AG

2. bbi-biotech GmbH

3. Danaher Corp

4. Sartorius AG

5. FUJIFILM Irvine Scientific Inc

6. Thermo Fisher Scientific Inc

7. Merck KGaA

8. F. Hoffmann-La Roche Ltd

9. Bio-Rad Laboratories Inc

 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific bioproduction market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific bioproduction market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific bioproduction market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440